Panacea Healthcare Solutions, a leader in revenue cycle and compliance solutions, is proud to announce the launch of RevenueRx: Drug Assistance Program, a full-service offering that helps hospitals and infusion centers ensure patients have access to essential medications—while improving reimbursement outcomes and easing administrative burden.
Health Technology Insights: KEPSA, MindHYVE.ai Partner to Launch AGI Initiatives in Kenya
RevenueRx is a tech-enabled, proactive solution that simplifies the complex process of securing pharmaceutical assistance for patients prescribed high-cost, brand-name medications. Through a combination of early patient screening, expert program management, and robust technology, Panacea delivers a streamlined process from referral to reimbursement.
“This program represents the intersection of patient advocacy and revenue optimization,” said Kevin Chmura, Chief Executive Officer of Panacea Healthcare Solutions. “With RevenueRx, we’re helping hospitals deliver essential medications to those in need while also maximizing their financial recovery—at no upfront cost to the provider. It’s a win for the patient and the health system alike.”
Health Technology Insights: New TriNetX Survey Reveals RWD and AI Trends in Drug Development
The program offers access to Manufacturer Free Drug, Co-Pay, and Foundation Assistance options while providing onsite or remote support, seamless pharmacy coordination, and a dedicated management team to oversee performance. Unlike retrospective-only models, RevenueRx begins at the point of care—screening patients as soon as treatment is prescribed to ensure no opportunity for assistance is missed.
“Our goal with RevenueRx is to take the complexity out of drug assistance,” said BreAnn Meadows, FHFMA, President of Panacea’s Revenue Integrity Division. “From regulatory compliance to patient communication to claims tracking, we handle the details so hospitals can focus on care delivery. It’s about elevating outcomes for both patients and providers.”
Backed by Panacea’s national team of revenue integrity experts, the program operates under a contingency fee model—meaning providers only pay when results are delivered. With demonstrated success in tripling recoveries compared to retrospective models, RevenueRx stands to make a meaningful impact on both patient access and healthcare finances.
Health Technology Insights: Concord Delivers China’s First Proton Therapy for Eye Cancer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source- PR Newswire
